======= EZH1 =======
== Gene Information ==
* **Official Symbol**: EZH1
* **Official Name**: enhancer of zeste 1 polycomb repressive complex 2 subunit
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2145|2145]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q92800|Q92800]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EZH1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EZH1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601674|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|EZH2 WD-Binding|
|SET|
|establishment of chromatin silencing|
|nucleosomal histone binding|
|chromatin silencing at telomere|
|histone H3-K27 methylation|
|ESC/E(Z) complex|
|histone-lysine N-methyltransferase activity|
|chromosome, telomeric region|
|chromatin organization involved in negative regulation of transcription|
|chromatin silencing|
|chromatin organization involved in regulation of transcription|
|histone lysine methylation|
|negative regulation of gene expression, epigenetic|
|hippocampus development|
|peptidyl-lysine methylation|
|histone methylation|
|limbic system development|
|protein alkylation|
|protein methylation|
|gene silencing|
|chromatin remodeling|
|pallium development|
|regulation of gene expression, epigenetic|
|transcription corepressor activity|
|macromolecule methylation|
|telencephalon development|
|methylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|forebrain development|
|chromatin binding|
|chromatin organization|
|brain development|
|head development|
|negative regulation of transcription by RNA polymerase II|
|peptidyl-amino acid modification|
|central nervous system development|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.79|
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.73|
|[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.86|
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|1.97|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12586
* **Expression level (log2 read counts)**: 5.79
{{:chemogenomics:nalm6 dist.png?nolink |}}